Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000912057-02-013487
Filing Date
2002-04-03
Accepted
2002-04-03 00:00:00
Documents
3
Period of Report
2002-05-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2075646zpre14a.htm PRE 14A 232990
3 G473666.JPG g473666.jpg GRAPHIC 6825
4 G857148.JPG g857148.jpg GRAPHIC 44021
  Complete submission text file 0000912057-02-013487.txt   285516
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: PRE 14A | Act: 34 | File No.: 000-21794 | Film No.: 02601020
SIC: 2836 Biological Products, (No Diagnostic Substances)